Growth Substances [Pharmacological Action]
Tree Number(s): D006133
MeSH Unique ID: D006133
- ribosomal protein L29 (Supplementary Concept)
- TFF1 protein, human (Supplementary Concept)
- CHI3L1 protein, human (Supplementary Concept)
- growth hormone-releasing peptide-2 (Supplementary Concept)
- tesamorelin (Supplementary Concept)
- mecasermin (Supplementary Concept)
- Endothelial Growth Factors (MeSH Term)
- Pituitary Adenylate Cyclase-Activating Polypeptide (MeSH Term)
- PR1P peptide (Supplementary Concept)
- angiogenin (Supplementary Concept)
- halofuginone (Supplementary Concept)
- tetrathiomolybdate (Supplementary Concept)
- tetra(4-N-methylpyridyl)porphine (Supplementary Concept)
- zhengguangmycin (Supplementary Concept)
- small inducible cytokine subfamily E, member 1 (Supplementary Concept)
- squalamine (Supplementary Concept)
- Anecortave (Supplementary Concept)
- fumagillin (Supplementary Concept)
- aflibercept (Supplementary Concept)
- roquinimex (Supplementary Concept)
- trebananib (Supplementary Concept)
- thymogen (Supplementary Concept)
- 2-(benzylsulfinyl)ethyl pyridin-3-ylmethylcarbamodithioate (Supplementary Concept)
- cytochalasin E (Supplementary Concept)
- pomalidomide (Supplementary Concept)
- 5-nitro-2-(3-phenylpropylamino)benzoic acid (Supplementary Concept)
- faricimab (Supplementary Concept)
- RC28-E protein (Supplementary Concept)
- volociximab (Supplementary Concept)
- endostar protein (Supplementary Concept)
- xanthohumol (Supplementary Concept)
- CKD732 (Supplementary Concept)
- Semaxinib (Supplementary Concept)
- CNMD protein, human (Supplementary Concept)
- intraovarian peptides (Supplementary Concept)
- fibroblast proliferation inhibitor (Supplementary Concept)
- alvocidib (Supplementary Concept)
- N(1), N(12)-diethylspermine (Supplementary Concept)
- sulA protein, E coli (Supplementary Concept)
- hemoregulatory peptide 5b (Supplementary Concept)
- viridiflorol (Supplementary Concept)
- tricyclodecane-9-yl-xanthogenate (Supplementary Concept)
- 2'-fluoro-5-ethylarabinosyluracil (Supplementary Concept)
- goralatide (Supplementary Concept)
- FR 167653 (Supplementary Concept)
- N-methyladenosine (Supplementary Concept)
- jasmonic acid (Supplementary Concept)
- alpha-naphthylphthalamic acid (Supplementary Concept)
- methyl jasmonate (Supplementary Concept)
- ethylene (Supplementary Concept)
- 12-oxophytodienoic acid (Supplementary Concept)
- 1-methylcyclopropene (Supplementary Concept)
- indoleacetic acid (Supplementary Concept)
- benzylaminopurine (Supplementary Concept)
- brassinolide (Supplementary Concept)
- ethephon (Supplementary Concept)
- daminozide (Supplementary Concept)
- gibberellic acid (Supplementary Concept)
- zeatin riboside (Supplementary Concept)
- pentafluoropropyl jasmonate (Supplementary Concept)
- N-(2-chloro-4-pyridyl)-N'-phenylurea (Supplementary Concept)
- Becaplermin (MeSH Term)
- Thalidomide (MeSH Term)
- Bevacizumab (MeSH Term)
- Ranibizumab (MeSH Term)
- Interleukin-12 (MeSH Term)
- Angiostatic Proteins (MeSH Term)
- Angiostatins (MeSH Term)
- Endostatins (MeSH Term)
- Tumor Necrosis Factor Ligand Superfamily Member 15 (MeSH Term)
- Interleukin-23 (MeSH Term)
- Sunitinib (MeSH Term)
- Lenalidomide (MeSH Term)
- O-(Chloroacetylcarbamoyl)fumagillol (MeSH Term)
- Angiopoietin-Like Protein 1 (MeSH Term)
- Ramucirumab (MeSH Term)
- Oncostatin M (MeSH Term)
- Abscisic Acid (MeSH Term)
- Isopentenyladenosine (MeSH Term)
- Kinetin (MeSH Term)
- Maleic Hydrazide (MeSH Term)
- Cytokinins (MeSH Term)
- Gibberellins (MeSH Term)
- Chlormequat (MeSH Term)
- Chlorpropham (MeSH Term)
- Triiodobenzoic Acids (MeSH Term)
- Zeatin (MeSH Term)
- Florigen (MeSH Term)
- Brassinosteroids (MeSH Term)
- Indoleacetic Acids (MeSH Term)